Skip to content
CNS Clinical Research

Durham, North Carolina

CNS clinical trials in Durham, NC

35 CNS studies are recruiting participants at sites in Durham as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Durham at a glance

  • 35 studies are recruiting at a site in Durham.
  • By phase: Phase 1/2 (4), Phase 2 (3), Phase 2/3 (1), Phase 3 (10), Phase 4 (1), No phase (9), Observational (7). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (23), university, hospital or other (11), government (1).
  • By research area: Epilepsy (15), Depression (6), Parkinson's Disease (6), ADHD (3), Migraine (3), Multiple Sclerosis (2).
  • Most recent update to one of these records: November 10, 2026.

Depression studies recruiting in Durham

Basic details from each study's public record (the 30 most recently updated of 35). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Families

    • No phase
    • Ages 12 to 100
    • All sexes
    Sponsor
    Duke University
    Study site
    Duke School of Nursing
    Registry record
    NCT06627764 · updated
  2. A New Intervention to Improve Function in Veterans With Anxiety and Depression

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    VA Office of Research and Development
    Study site
    Durham VA Medical Center, Durham, NC
    Registry record
    NCT06188923 · updated
  3. Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder

    • No phase
    • Ages 22 and older
    • All sexes
    Sponsor
    Pulvinar Neuro, LLC
    Study site
    Qortical Clinical Partners
    Registry record
    NCT07282678 · updated
  4. Allopregnanolone (Zuranolone) in Post-stroke Depression

    • Phase 2
    • Ages 21 to 65
    • All sexes
    Sponsor
    Duke University
    Study site
    Duke South Neurology Clinic 1L
    Registry record
    NCT06759558 · updated
  5. Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking

    • No phase
    • Ages 21 and older
    • All sexes
    Sponsor
    Medical University of South Carolina
    Study site
    Duke University School of Medicine
    Registry record
    NCT07050355 · updated
  6. Adaptive Coping Skills Training to Improve Psychological Distress Among Cardiorespiratory Failure Survivors

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Duke University
    Study site
    Duke University Medical Center
    Registry record
    NCT06538246 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Durham, NC on ClinicalTrials.gov.

ADHD studies recruiting in Durham

  1. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

    • Phase 4
    • From 48 months, up to 69 months
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Study site
    Duke University
    Registry record
    NCT04781140 · updated
  2. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

    • Observational
    • Ages 0 to 20
    • All sexes
    Sponsor
    Duke University
    Study site
    Duke University Health System
    Registry record
    NCT04278404 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Durham, NC on ClinicalTrials.gov.

Parkinson's disease studies recruiting in Durham

  1. A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Duke Cancer Institute ( Site 6049)
    Registry record
    NCT06952504 · updated
  2. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

    • Phase 3
    • Ages 50 to 85
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Duke University Medical Center
    Registry record
    NCT07174310 · updated
  3. A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

    • Phase 3
    • Ages 45 to 75
    • All sexes
    Sponsor
    BlueRock Therapeutics
    Study site
    Duke Neurological Disorders Clinic
    Registry record
    NCT06944522 · updated
  4. A Study of Buntanetap in Participants With PD

    • Phase 2/3
    • Ages 40 to 85
    • All sexes
    Sponsor
    Annovis Bio Inc.
    Study site
    Duke Department of Neurosurgery
    Registry record
    NCT07284784 · updated
  5. A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

    • Phase 2
    • Ages 30 to 80
    • All sexes
    Sponsor
    Appello Pharmaceuticals, Inc.
    Study site
    Duke Neurological Disorders Clinic (Site #210)
    Registry record
    NCT07432958 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Durham, NC on ClinicalTrials.gov.

Multiple sclerosis (MS) studies recruiting in Durham

  1. Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

    • Phase 1/2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Tr1X, Inc.
    Study site
    Duke University
    Registry record
    NCT07477639 · updated
  2. Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

    • Observational
    • All ages
    • Female participants
    Sponsor
    Biogen
    Study site
    IQVIA US Office
    Registry record
    NCT05658497 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Durham, NC on ClinicalTrials.gov.

Epilepsy studies recruiting in Durham

  1. Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

    • Phase 3
    • Ages 4 to 55
    • All sexes
    Sponsor
    SK Life Science, Inc.
    Study site
    Duke University Clinical Research at Pickett Road
    Registry record
    NCT05219617 · updated
  2. A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

    • Phase 3
    • Ages 12 and older
    • All sexes
    Sponsor
    Xenon Pharmaceuticals Inc.
    Study site
    Duke University Clinical Research
    Registry record
    NCT05667142 · updated
  3. A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Xenon Pharmaceuticals Inc.
    Study site
    Duke University Clinic
    Registry record
    NCT05716100 · updated
  4. ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

    • Phase 1/2
    • Ages 2 to 12
    • All sexes
    Sponsor
    Ionis Pharmaceuticals, Inc.
    Study site
    Duke University Health Systems
    Registry record
    NCT07531745 · updated
  5. Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Neurona Therapeutics
    Study site
    Duke University Hospital
    Registry record
    NCT05135091 · updated
  6. A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

    • Phase 3
    • Ages 2 and older
    • All sexes
    Sponsor
    Epygenix
    Study site
    Duke University Health System
    Registry record
    NCT04462770 · updated
  7. Diagnosing Epilepsy To EffeCT Change

    • No phase
    • Ages 18 to 75
    • All sexes
    Sponsor
    Epiminder America, Inc.
    Study site
    Duke University
    Registry record
    NCT07110337 · updated
  8. A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Encoded Therapeutics
    Study site
    Duke Children's Hospital & Health Center
    Registry record
    NCT05419492 · updated
  9. Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

    • Observational
    • Ages 18 to 75
    • All sexes
    Sponsor
    Epiminder America, Inc.
    Study site
    Duke University
    Registry record
    NCT07110454 · updated
  10. Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Duke University
    Study site
    Duke University Health System
    Registry record
    NCT06545643 · updated
  11. Overnight TI in TLE

    • No phase
    • Ages 18 to 70
    • All sexes
    Sponsor
    Duke University
    Study site
    Anphy Lab - Inside Hock Plaza
    Registry record
    NCT07434986 · updated
  12. Temporal Interference Brain Stimulation for Adults With Drug-Resistant Epilepsy Undergoing Stereo-EEG Monitoring

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Duke University
    Study site
    Duke University Medical Center
    Registry record
    NCT07764718 · updated
  13. An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

    • Phase 3
    • Ages 2 to 55
    • All sexes
    Sponsor
    Epygenix
    Study site
    Duke University Medical Center
    Registry record
    NCT05066217 · updated
  14. B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Duke University
    Study site
    Duke University Medical Center
    Registry record
    NCT07271966 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Durham, NC on ClinicalTrials.gov.

Migraine studies recruiting in Durham

  1. A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

    • Phase 3
    • Ages 18 to 45
    • Female participants
    Sponsor
    Pfizer
    Study site
    Carolina Women's Research and Wellness Center
    Registry record
    NCT06641466 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Durham, NC on ClinicalTrials.gov.

Ask about studies near Durham

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call